LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 45.70
-2.30 (-4.79%)
Jul 30, 2026, 11:15 AM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 3.87 billion as of July 29, 2026. Its market cap has increased by 112.39% in one year.
Market Cap
3.87B
Enterprise Value
3.16B
Revenue
414.67M
Ranking
n/a
PE Ratio
10.04
Stock Price
45.70
ChartMarket Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 3.87B, an increase of 124.65%. That is a compound annual growth rate of 3.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.87B | 47.92% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 5.98B |
| SCI Pharmtech | 5.92B |
| Orient Pharma | 5.49B |
| Panion & Bf Biotech | 5.03B |
| Orient EuroPharma | 4.07B |
| Easywell Biomedicals | 4.05B |
| Tien Liang BioTech | 3.36B |
| Yoda Pharmaceuticals | 2.97B |